StonvexLoading…
StonvexStonvexStonvexCore line items from VRSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.66B | $1.56B | $1.49B | $1.42B |
Operating Income | $1.12B | $1.06B | $1.00B | $943.10M |
Net Income | $825.70M | $785.70M | $817.60M | $673.80M |
EPS (Diluted) | $8.81 | $8.00 | $7.90 | $6.24 |
Total Assets | $1.33B | $1.41B | $1.75B | $1.73B |
Total Liabilities | $3.48B | $3.36B | $3.33B | $3.30B |
Cash & Equivalents | $307.90M | $206.70M | $240.10M | $373.60M |
Free Cash Flow OCF − CapEx | $1.07B | $874.50M | $808.00M | $803.70M |
Shares Outstanding | 91.90M | 95.00M | 101.30M | 105.30M |